Meet Modulight Laser Experts

Meet Modulight Laser Experts

EQTC 2023

October 16-20, 2023, Hannover, Germany

AAO 2023

November 3-6, 2023, San Francisco, CA
BOOTH # 5250

OPTICA Quantum Industry Summit

November 14-15, 2023, Ligentec, Lausanne, Switzerland

Early Cancer Detection & Biomarker Forum

November 21-22, 2023, Berlin, Germany

EPIC Meeting on Photonics assisted Cancer Pathology and Surgery

November 29-30, 2023, Antwerp, Belgium


December 2–6, 2023, Boston, MA
BOOTH # 361


January 4-8, 2023, New York, NY

Photonics West 2024

January 27 – February 1, 2024, San Francisco, CA
BOOTH # 1267

Recent conference presentations by Modulight

Modulight’s papers in BIOS 2022:

Ophthalmic laser platform utilizing AI to enhance treatment planning of liposomal drug release
Eero Koivumäki, Laura Vesala, Jukka-Pekka Alanko, Timo Tanila, Petteri Uusimaa, Modulight Corporation (Finland)

Configurable multi-wavelength laser light engine for endoscopic fluorescence imaging
Zoe Ylöniemi, Visa Kaivosoja, Lasse Orsila, Tero Vierimaa, Petteri Uusimaa, Modulight Corporation (Finland)

Laser illumination platform with real-time spectral monitoring and treatment
Visa Kaivosoja, Robert Perttilä, Elias Kokko, Timo Tanila, Zoe Ylöniemi, Petteri Uusimaa, Modulight Corporation (Finland)

Theranostic laser system for multi-function drug activation and monitoring
Robert Perttilä, Visa Kaivosoja, Elias Kokko, Zoe Ylöniemi, Lasse Orsila, Modulight Corporation (Finland), Tampere Univ. Hospital (Finland); Timo Tanila, Petteri Uusimaa,Modulight Corporation (Finland)

Light-activated drug release using an automated well plate illuminator
Laura Vesala, Robert Perttilä, Elias Kokko, Lasse Orsila, Modulight Corporation (Finland), Tampere Univ. Hospital (Finland); Petteri Uusimaa, Modulight Corporation (Finland)

Modulight in EPIC World Photonics Technology Summit 2022

Design, experiences and opportunities of cloud based medical devices enabling improvement of treatment efficacy by analytics
Petteri Uusimaa, CTO at Modulight Corporation (Finland)

Modulight’s papers in OPTO 2022:

Riina Ulkuniemi, Petri Melanen, Jari Nikkinen, Jari Ovaskainen, Petteri Uusimaa, Modulight Corporation (Finland)

Modulight’s papers in LASE 2022:

Riina Ulkuniemi, Ilpo Suominen, Ville Vilokkinen, Jari Sillanpää, Petteri Uusimaa, Modulight Corporation (Finland)
Anna Filipchuk, Kostiantyn Nechay, Riina Ulkuniemi, Soile Talmila, Petteri Uusimaa, Antti Saarela, Modulight Corporation (Finland)

Modulight in Lasers & Photonics Marketplace Seminar 2022:

Successful Transformations: Emerging from Bootstrapping to Leadership Roles in the Photonics Sector
Moderator: John Dexheimer; Panelists: Jennifer Cable – Thorlabs, Debbie Gustafson – Energetiq Technology, Seppo Orsila – Modulight Corporation, Wilhelm Kaenders, PhD – Toptica Photonics, Yves Dzialowski

Modulight’s papers in BIOS 2021:

Configurable cloud-connected iPad controlled multimodal ophthalmic laser
Jukka-Pekka Alanko, Visa Kaivosoja, Ivan Baldin, Timo Tanila, Eero Koivumäki, Petteri Uusimaa, Zoe Ylöniemi, Modulight, Inc. (Finland)

Configurable cloud based medical laser platform with real-time treatment monitoring
Visa Kaivosoja, Zoe Ylöniemi, Juha Lemmetti, Timo Tanila, Lasse Orsila, Petteri Uusimaa, Modulight, Inc. (Finland)

Cloud based medical laser platform for phototherapy and treatment monitoring for glioblastoma
Zoe Ylöniemi, Visa Kaivosoja, Juha Lemmetti, Timo Tanila, Eero Koivumäki, Lasse Orsila, Petteri Uusimaa, Modulight, Inc. (Finland)

Towards High-Throughput Light-Activated Drug Discovery with Automated Plate Illuminator
Robert Perttilä, Modulight, Inc. (Finland); John Roque, The Univ. of Texas at Arlington (United States); Lasse Orsila, Modulight, Inc. (Finland), Tampere Univ. Hospital (Finland); Zoe Ylöniemi, Elias Kokko, Modulight, Inc. (Finland); Sherri A. McFarland, The Univ. of Texas at Arlington (United States); Petteri Uusimaa, Modulight, Inc. (Finland)

Medical laser platform to induce and monitor drug release from nano-constructs in vitro and in vivo
Zoe Ylöniemi, Johannes Kivelä, Elias Kokko, Robert Perttilä, Visa Kaivosoja, Lasse Orsila, Petteri Uusimaa, Modulight, Inc. (Finland)

Configurable automated well plate illuminator for in vitro research in drug discovery and optogenetics
Elias Kokko, Robert Perttilä, Modulight, Inc. (Finland); Lasse Orsila, Modulight, Inc. (Finland), Tampere Univ. Hospital (Finland); Zoe Ylöniemi, Modulight (Finland); Johannes Kivelä, Petteri Uusimaa, Modulight, Inc. (Finland)

Modulight in Photonics West Industry talk 2021:

Lasers hold promise in oncology for both curative and palliative purposes
Seppo Orsila, CEO & Chairman, Modulight, Inc.

Modulight’s papers in OPTO 2021:

High-temperature AlGaInAs-based 25G DML-DFB lasers operating in o-band for datacenter use
Antti Saarela, Petri Melanen, Ville Vilokkinen, Petteri Uusimaa, Modulight, Inc. (Finland); Riina Ulkuniemi, Modulight (Finland)

Modulight’s papers in LASE 2021:

Individually addressable visible laser arrays for display and printing applications
Riina Ulkuniemi, Ville Vilokkinen, Ilpo Suominen, Soile Talmila, Jari Sillanpää, Petteri Uusimaa, Modulight, Inc. (Finland)

High-efficiency vertically-emitting chipsets for 3D and proximity sensing
Kostiantyn Nechay, Riina Ulkuniemi, Anna Filipchuk, Timo Hartikainen, Visa Kaivosoja, Riina Hietikko, Jari Nikkinen, Jari Sillanpää, Petri Melanen, Ville Vilokkinen, Soile Talmila, Petteri Uusimaa, Modulight, Inc. (Finland)

Eye-safe laser illuminators for long-reach LiDAR and gated imaging in harsh weather conditions
Lasse Orsila, Visa Kaivosoja, Petri Melanen, Petteri Uusimaa, Modulight, Inc. (Finland)

High-efficiency and reliable pump lasers for fiber lasers
Jari Nikkinen, Soile Talmila, Ville Vilokkinen, Petri Melanen, Antti Saarela, Lasse Orsila, Jari Sillanpää, Petteri Uusimaa, Seppo Orsila, Modulight, Inc. (Finland)

Long-range all-solid-state flash LiDAR sensor for autonomous driving
Juha Lemmetti, Niklas Sorri, Ilkka Kallioniemi, Petri Melanen, Petteri Uusimaa, Modulight, Inc. (Finland)

Articles by Modulight and customers

  • All
  • 2022
  • 405 nm
  • 488 nm
  • 5-ALA
  • 630 nm
  • 633 nm
  • 690 nm
  • 690nm
  • 6XX nm
  • 780 nm
  • 808 nm
  • AbPC
  • abscess
  • age-related macular degeneration
  • AI
  • AMD
  • antibiotics
  • antimicrobial
  • ARPE-19
  • AU-011
  • Barrett's esophagus
  • benzoporphyrin
  • BIOS
  • bladder cancer
  • BPD
  • brain cancer
  • breast cancer
  • cancer
  • Cancer therapy
  • carcinomatosis
  • Cell
  • cetuximab
  • checkpoint inhibitors
  • clinical
  • clinical trial
  • clinical trials
  • COD
  • colon cancer
  • colonoscopy
  • conjugated to the photosensitizer
  • CSC
  • CSR
  • cystoscopy
  • D2 ine
  • DBR
  • DBR laser
  • DFB
  • DME
  • drug delivery
  • drug resistance
  • EBL
  • Electron Beam Lithography
  • endoscopy
  • esophageal cancer
  • etching
  • ex vivo
  • external cavity
  • fERG
  • fimaporfin
  • fluorescence
  • fluorescence excitation
  • fluorescence imaging
  • fluorescence-guided surgery
  • fluorescent imaging
  • fluorophore activation
  • focal electroretinography
  • frequency stabilization
  • fundus imaging
  • glioblastoma
  • grating
  • H&N cancer
  • head & neck cancer
  • HeatShockProtein
  • high-grade dysplasia
  • high-speed imaging
  • HSP90
  • hypoxia
  • ICG
  • IL-15
  • illumination system
  • immune checkpoints
  • immunecheckpoints
  • immunotherapy
  • in vitro
  • in vivo
  • interferometry
  • interleukin
  • intratumoral
  • iPDT
  • IR700
  • IRDye700
  • IRDye700DX
  • laser
  • laser development
  • laser technology
  • light activation
  • light delivery
  • liposomes
  • Lung cancer
  • Melanoma
  • methylene blue
  • metrology
  • ML6500
  • ML6600
  • ML6710i
  • ML7710
  • ML8500
  • Modulight authors
  • Modulight Cloud
  • MRSA
  • multi-wavelength
  • nAMD
  • nanotechnology
  • narrow linewidth
  • oncology
  • ophthalmic treatments
  • ophthalmology
  • OPTO
  • oral carcinoma
  • ovarian cancer
  • pancreatic cancer
  • PCV
  • PDT
  • peritoneal cavity
  • Photochemical Internalization
  • Photodynamic therapy
  • photofrin
  • photoimmunoconjugates
  • Photoimmunotherapy
  • Photonics West
  • photosensitizer
  • photothermal therapy
  • PIAS
  • PIC-Nal
  • PIT
  • plate reader
  • platinum nanoparticles
  • preclinical
  • quantum computing
  • Quantum West
  • Retina
  • retinal diseases
  • RGB
  • ROS detection
  • Rubidium
  • RWG
  • single-frequency
  • SLA
  • slit lamp adapter
  • speckle removal
  • spectroscopy
  • SPIE BIOS 2023
  • SPIE OPTO 2023
  • SPIE Quantum West 2023
  • SPIM
  • stem cells
  • T-cell response
  • targeted cancer PDT
  • targeted photoimmunotherapy
  • targeted therapies
  • targeted therapy
  • thermal dosimetry
  • tumor
  • UMD
  • Uveal Melanoma
  • vascular-targeted PDT
  • verteporfin
  • virus-like conjugates

Targeting Borrelia burgdorferi HtpG with a berserker molecule, a strategy for anti-microbial development

Dave L. Carlson, Mark Kowalewski, Khaldon Bodoor, Matthew R. Redinbo, Neil Spector, Timothy A.J. Haystead

Photoimmunotechnology as a powerful biological tool for molecular-based elimination of target cells and microbes, including bacteria, fungi and viruses

Tadayuki Iwase, Kimihiro Ito, Takashi Nishimura, Kei Miyakawa, Akihide Ryo, Hisataka Kobayashi, Makoto Mitsunaga

Fluorescence-guided photoimmunotherapy using targeted nanotechnology and ML7710 to manage peritoneal carcinomatosis

Barry J. Liang, Sumiao Pang, Robert Perttilä, Chen-Hua Ma, Payal Srivastava, Brandon Gaitan, Aaron J. Sorrin, Nada Fadul, Zoe Ylöniemi, Dana M. Roque, Tayyaba Hasan, Petteri Uusimaa, Huang-Chiao Huang

Photodynamic Therapy of an Abdominal Abscess at the Time of Percutaneous Drainage

Timothy M. Baran, Ashwani Kumar Sharma

Intratumoral interleukin-15 improves efficacy of near-infrared photoimmunotherapy

Hiroshi Fukushima, Aki Furusawa, Takuya Kato, Hiroaki Wakiyama, Seiichiro Takao, Shuhei Okuyama, Peter L. Choyke, Hisataka Kobayashi

Transient fluid flow improves photoimmunoconjugate delivery and photoimmunotherapy efficacy

Aaron J. Sorrin, Keri Zhou, Katherine May, Cindy Liu, Kathryn McNaughton, Idrisa Rahman, Barry J. Liang, Imran Rizvi, Dana M. Roque, Huang-Chiao Huang

Immune checkpoint inhibition combined with targeted therapy using a novel virus‑like drug conjugate induces complete responses in a murine model of local and distant tumors

Ruben V. Huis in ‘t Veld, Sen Ma, Rhonda C. Kines, Anneli Savinainen, Cadmus Rich, Ferry Ossendorp, Martine J. Jager

Fluorescence-guided, targeted photochemotherapy of peritoneal carcinomatosis

Barry J. Liang, Robert Perttilä, Sumiao Pang, Chen-Hua Ma, Payal Srivastava, Brandon Gaitan, Aaron J. Sorrin, Zoe Ylöniemi, Dana Roque, Tayyaba Hasan, Petteri Uusimaa, Huang-Chiao Huang

Novel ophthalmic laser system paired with focal electroretinography for subthreshold laser therapy of DME

Jukka-Pekka Alanko, Eero Koivumäki, Laura Vesala, Johannes Kivelä, Zoe Ylöniemi, Petteri Uusimaa, Ossi Kaikkonen, Teemu Turunen, Jaakko Nieminen, Jani Tirronen

Output beam engineering with 2-step ridge etching

Riina Ulkuniemi, Ville Vilokkinen, Petri Melanen, Petteri Uusimaa

Laser platform and light delivery optimization for bladder cancer treatment with a novel photosensitive drug

Zoe Ylöniemi, Elias Kokko, Visa Kaivosoja, Ana Colucci, Eerika Suokas, Jukka-Pekka Alanko, Petteri Uusimaa, Modulight Corp.

Novel ophthalmic PDT laser platform to target oncology and various other retinal indications

Laura Vesala, Eero Koivumäki, Jukka-Pekka Alanko, Timo Tanila, Ivan Baldin, Zoe Ylöniemi, Petteri Uusimaa, Modulight Corp.

Optimization of light delivery for non-muscle invasive bladder cancer PDT

Elias Kokko, Robert Perttilä, Zoe Ylöniemi, Visa Kaivosoja, Jukka-Pekka Alanko, Petteri Uusimaa, Modulight Corp.

Configurable multiwavelength narrow linewidth laser system for quantum applications

Kostiantyn Nechay, Luukas Kuusela, Ossi Mäkinen, Riina Ulkuniemi, Pekko Sipilä, Kalle Palomäki, Petteri Uusimaa

Optimization and fabrication of 780 nm DFB lasers for quantum systems

Riina Ulkuniemi, Luukas Kuusela, Timo Aho, Petteri Uusimaa

High aspect ratio DBR gratings for narrow linewidth red lasers

Luukas Kuusela, Riina Ulkuniemi, Timo Aho, Petteri Uusimaa

Light-induced cytotoxicity in cells utilizing an automated well plate illuminator

Laura Vesala, Robert Perttilä, Elias Kokko, Johannes Kivelä, Lasse Orsila, Petteri Uusimaa

Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response

Takuya Kato, Hiroshi Fukushima, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Hideyuki Furumoto, Shuhei Okuyama, Seiichiro Takao, Peter L. Choyke, Hisataka Kobayashi

A Non-Invasive Deep Photoablation Technique to Inhibit DCIS Progression and Induce Antitumor Immunity

Kensuke Kaneko, Hiroshi Nagata, Xiao-Yi Yang, Joshua Ginzel, Zachary Hartman, Jeffrey Everitt, Philip Hughes, Timothy Haystead, Michael Morse, Herbert Kim Lyerly, Takuya Osada

Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy

Hiroaki Wakiyama, Takuya Kato, Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Hideyuki Furumoto, Hiroshi Fukushima, Shuhei Okuyama, Peter L. Choyke, Hisataka Kobayashi

Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal effect against breast cancers

Kensuke Kaneko, Chaitanya R Acharya, Hiroshi Nagata, Xiao Yang, Zachary Conrad Hartman, Amy Hobeika, Philip F Hughes, Timothy A J Haystead, Michael A Morse, Herbert Kim Lyerly, Takuya Osada

Towards Photodynamic Image-Guided Surgery of Head and Neck Tumors: Photodynamic Priming Improves Delivery and Diagnostic Accuracy of Cetuximab-IRDye800CW

Chanda Bhandari, John Fakhry, Menitte Eroy, Jane Junghwa Song, Kimberley Samkoe, Tayyaba Hasan, Kenneth Hoyt, Girgis Obaid

Ophthalmic laser platform utilizing AI to enhance treatment planning of liposomal drug release

Eero Koivumäki, Laura Vesala, Jukka-Pekka Alanko, Timo Tanila, Petteri Uusimaa, Modulight Corporation (Finland)

Configurable multi-wavelength laser light engine for endoscopic fluorescence imaging

Zoe Ylöniemi, Visa Kaivosoja, Lasse Orsila, Tero Vierimaa, Petteri Uusimaa, Modulight Corporation (Finland)

Antitumor Effect and Induced Immune Response Following Exposure of Hexaminolevulinate and Blue Light in Combination with Checkpoint Inhibitor in an Orthotopic Model of Rat Bladder Cancer

Laureline Lamy, Jacques Thomas, Agnès Leroux, Jean-François Bisson, Kari Myren, Aslak Godal, Gry Stensrud, Lina Bezdetnaya

CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma model

Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Hiroaki Wakiyama, Takuya Kato, Hideyuki Furumoto, Hiroshi Fukushima, Shuhei Okuyama, Peter L. Choyke, Hisataka Kobayashi

Nanobody-targeted photodynamic therapy for the treatment of feline oral carcinoma: a step towards translation to the veterinary clinic

Irati Beltrán Hernández, Guillaume C.M. Grinwis, Alessia Di Maggio, Paul M.P. van Bergen en Henegouwen, Wim E. Hennink, Erik Teske, Jan W. Hesselink, Sebastiaan A. van Nimwegen, Jan A. Mol, Sabrina Oliveira

Rapid Depletion of Intratumoral Regulatory T cells Induces Synchronized CD8 T and NK Cell Activation and IFN-γ-dependent Tumor Vessel Regression

Yutaka Kurebayashi, Colleen P. Olkowski, Kelly C. Lane, Olga V. Vasalatiy, Biying C. Xu, Ryuhei Okada, Aki Furusawa, Peter L. Choyke, Hisataka Kobayashi, Noriko Sato

Virus-like particle-drug conjugates induce protective, long-lasting adaptive anti-tumor immunity in the absence of specifically targeted tumor antigens

Rhonda C Kines, Cynthia D Thompson, Sean Spring, Zhenyu Li, Elisabet de los Pinos, Stephen Monks, John T Schiller

Photochemical Internalization Enhanced Vaccination Is Safe, and Gives Promising Cellular Immune Responses to an HPV Peptide-Based Vaccine in a Phase I Clinical Study in Healthy Volunteers

Tone Otterhaug, Sylvia Janetzki, Marij J. P. Welters, Monika Håkerud, Anne Grete Nedberg, Victoria Tudor Edwards, Sanne Boekestijn, Nikki M. Loof, Pål Kristian Selbo, Hans Olivecrona, Sjoerd H. van der Burg, Anders Høgset

Near-infrared Absorbing Ru(II) Complexes Act as Immunoprotective Photodynamic Therapy (PDT) Agents Against Aggressive Melanoma

Liubov M. Lifshits, A. Roque III, Prathyusha Konda, Susan Monro, Houston D. Cole, David von Dohlen, Susy Kim, Gagan Deep, Randolph P. Thummel, Colin G. Cameron, Shashi Gujar, Sherri A. McFarland

Breaking the barrier: an osmium photosensitizer with unprecedented hypoxic phototoxicity for real world photodynamic therapy

John A. Roque III, Patrick C. Barrett, Houston D. Cole, Liubov M. Lifshits, Ge Shi, Susan Monro, David von Dohlen, Susy Kim, Nino Russo, Gagan Deep, Colin G. Cameron, Marta E. Alberto, Sherri A. McFarland

Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumors

Kensuke Kaneko, Takuya Osada, Michael A. Morse, William R. Gwin, Joshua D. Ginzel, Joshua C. Snyder, Xiao-Yi Yang, Cong-Xiao Liu, Márcio A. Diniz, Khaldon Bodoor, Philip F. Hughes, Timothy AJ. Haystead, H. Kim Lyerly

High-resolution optoacoustic imaging of tissue responses to vascular-targeted therapies

Katja Haedicke, Lilach Agemy, Murad Omar, Andrei Berezhnoi, Sheryl Roberts, Camila Longo-Machado, Magdalena Skubal, Karan Nagar, Hsiao-Ting Hsu, Kwanghee Kim, Thomas Reiner, Jonathan Coleman, Vasilis Ntziachristos, Avigdor Scherz, Jan Grimm

Combination of ALA-induced fluorescence-guided resection and intraoperative open photodynamic therapy for recurrent glioblastoma: case series on a promising dual strategy for local tumor control

Stephanie Schipmann, Michael Müther, Louise Stögbauer, Sebastian Zimmer, Benjamin Brokinkel, Markus Holling, Oliver Grauer, Eric Suero Molina, Nils Warneke, Walter Stummer

Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging

Henriette S. de Bruijn, Vida Mashayekhi, Tom J.L. Schreurs, Pieter B.A.A. van Driel, Gustav J. Strijkers, Paul J. van Diest, Clemens W.G.M. Lowik, Ann L.B. Seynhaeve, Timo L.M. ten Hagen, Jeanine J. Prompers, Paul M.P. van Bergen en Henegouwen, Dominic J. Robinson, Sabrina Oliveira

Breaking the selectivity‑uptake trade‑off of photoimmunoconjugates with nanoliposomal irinotecan for synergistic multi‑tier cancer targeting

Barry J. Liang, Michael Pigula, Yan Baglo, Daniel Najafali , Tayyaba Hasan, Huang‑Chiao Huang

Porphyrin-lipid assemblies and nanovesicles overcome ABC transporter-mediated photodynamic therapy resistance in cancer cells

Yan Baglo, Barry J. Liang, Robert W. Robey, Suresh V. Ambudkar, Michael M. Gottesman, Huang-Chiao Huang

Effects and side-effects of plasmonic photothermal therapy in brain tissue

Yue He, Kristoffer Laugesen, Dana Kamp, Salik Ahmad Sultan, Lene Broeng Oddershede, Liselotte Jauffred

Bioactive glass ions induce efficient osteogenic differentiation of human adipose stem cells encapsulated in gellan gum and collagen type I hydrogels

Kaisa Vuornos, Miina Ojansivu, Janne T. Koivisto, Heikki Häkkänen, Birhanu Belay, Toni Montonen, Heini Huhtala, Minna Kääräinen, Leena Hupa, Minna Kellomäki, Jari Hyttinen, Janne A. Ihalainen, Susanna Miettinen

Irradiance controls photodynamic efficacy and tissue heating in experimental tumours: implication for interstitial PDT of locally advanced cancer

Gal Shafirstein, David A. Bellnier, Emily Oakley, Sasheen Hamilton, Michael Habitzruther, Lawrence Tworek, Alan Hutson, Joseph A. Spernyak, Sandra Sexton, Leslie Curtin, Steven G. Turowski, Hassan Arshad, Barbara Henderson

The effect of light sensitizer localization on the stability of indocyanine green liposomes

Tatu Lajunen, Riikka Nurmi, Danny Wilbie, Teemu Ruoslahti, Niklas G. Johansson, Ossi Korhonen, Tomasz Rog, Alex Bunker, Marika Ruponen, Arto Urtti

Platinum nanoparticles: a non-toxic, effective and thermally stable alternative plasmonic material for cancer therapy and bioengineering

Akbar Samadi, Henrik Klingberg, Liselotte Jauffred, Andreas Kjær, Poul Martin Bendix, Lene B. Oddershede

An Infrared Dye–Conjugated Virus-like Particle for the Treatment of Primary Uveal Melanoma

Rhonda C. Kines, Isabella Varsavsky, Sanghamitra Choudhary, Debaditya Bhattacharya, Sean Spring, Roger McLaughlin, Shin J. Kang, Hans E. Grossniklaus, Demetrios Vavvas, Stephen Monks, John R. MacDougall, Elisabet de los Pinos, and John T. Schiller

WST11 Vascular Targeted Photodynamic Therapy Effect Monitoring by Multispectral Optoacoustic Tomography (MSOT) in Mice

Volker Neuschmelting, Kwanghee Kim, Jaber Malekzadeh-Najafabadi, Sylvia Jebiwott, Jaya Prakash, Avigdor Scherz, Jonathan A. Coleman, Moritz F. Kircher, Vasilis Ntziachristos

Fast quantitative ROS detection based on dual-color single rare-earth nanoparticle imaging reveals signaling pathway kinetics in living cells

M. Abdesselem, R. Ramodiharilafy, L. Devys, T. Gacoin, A. Alexandrou, C. I. Bouzigues

Disulfonated tetraphenyl chlorin (TPCS2a)-induced photochemical internalisation of bleomycin in patients with solid malignancies: a phase 1, dose-escalation, first-in-man trial

Ahmed A Sultan, Waseem Jerjes, Kristian Berg, Anders Høgset, Charles A Mosse, Rifat Hamoudi, Zaid Hamdoon, Celia Simeon, Dawn Carnell, Martin Forster, Colin Hopper

EGFR targeted nanobody–photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer

Pieter B.A.A. van Driel, Martin C. Boonstra, Maxime D. Slooter, Raimond Heukers, Marieke A. Stammes, Thomas J.A. Snoeks, Henriette S. de Bruijn, Paul J. van Diest, Alexander L. Vahrmeijer, Paul M.P. van Bergen en Henegouwen, Cornelis J.H. van de Velde, Clemens W.G.M. Löwik, Dominic J. Robinson, Sabrina Oliveira

Detection of colorectal polyps in humans using an intravenously administered fluorescent peptide targeted against c-Met

Jacobus Burggraaf, Ingrid M C Kamerling, Paul B Gordon, Lenneke Schrier, Marieke L de Kam, Andrea J Kales, Ragnar Bendiksen, Bård Indrevoll, Roger M Bjerke, Siver A Moestue, Siavash Yazdanfar, Alexandra M J Langers, Marit Swaerd-Nordmo, Geir Torheim, Madhuri V Warren, Hans Morreau, Philip W Voorneveld, Tessa Buckle, Fijs W B van Leeuwen, Liv-Ingrid Ødegårdstuen, Grethe T Dalsgaard, Andrew Healey, James C H Hardwick

Let’s meet at the next conference or trade show!

    First name *

    Family name *

    Company or affiliation *